The global joint pain injections market is predicted to register a CAGR of 8.56% and is expected to generate revenue of $7045.1 million by 2030. The base year considered for the studied market is 2021 and the forecasting period is from 2022 to 2030.
Joint pain injections are medicinal fluids inserted into the patient’s body for faster relief from severe pain. Moreover, joint pain injections are used to reduce joint inflammation.
GLOBAL JOINT PAIN INJECTIONS MARKET FORECAST 2022-2030
Global Market by Joint Type (Knee, Shoulder and Elbow, Hip, Foot and Ankle, Other Joint Types) Market by Injection Type (Hyaluronic Acid, Corticosteroid, Other Drugs) Market by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels) by Geography
The global joint pain injections market is predicted to register a CAGR of 8.56% and is expected to generate revenue of $7045.1 million by 2030. The base year considered for the studied market is 2021 and the forecasting period is from 2022 to 2030.
Joint pain injections are medicinal fluids inserted into the patient’s body for faster relief from severe pain. Moreover, joint pain injections are used to reduce joint inflammation.
To learn more about this report, request a free sample copy
Key factors propelling the global joint pain injections market growth:
- Bone and joint-related diseases in the geriatric population
- Growing number of sport injuries
- Sports injuries are caused due to direct impact or the application of force larger than the body part’s withstanding capability.
- The most common sports injuries are sprains, strains, joint injuries, and bruises.
- Prevalence of musculoskeletal disorders
Major growth restraining factors:
- High costs of joint repair therapies
- The high cost of joint repair therapies is one of the key factors hampering the growth of the global joint pain injections market.
- According to data published by Arthritis Foundation 2020, a single-knee allograft costs around $14,000 in the United States.
- Side effects associated with joint repair injections
The report scope of the global joint pain injections market includes the segmentation analysis based on joint type, injection type, and distribution channel. One of these segments is further classified to provide a detailed analysis of the studied market.
Market by Joint Type:
- Knee
- Knee is the highest revenue-generating joint type.
- Increasing sports participation in the region, as well as aging, are the main drivers bolstering the prevalence of knee injuries.
- For instance, according to a study published on NCBI in 2018, sports injuries comprise around 80% of musculoskeletal injuries, with knee injuries holding a significant share.
- Hip
- Hip is the fastest-growing segment under the joint type category.
- Hip injuries are commonly witnessed in sports medicine, particularly among certain groups of athletes, such as dancers, runners, and soccer players.
- Shoulder and Elbow
- Foot and Ankle
- Other Joint Types
Geographically, the global joint pain Injections market has been segmented based on four major regions, which includes:
- North America: The United States and Canada
- North America holds the highest market share in the global joint pain injections market.
- In North America, the United States is the largest market for joint pain injections.
- According to a report published by the United States Department of Health & Human Services in the year 2018, nearly 700,000 knee replacement surgeries in the United States are conducted annually.
- Europe: The United Kingdom, Germany, Italy, France, Spain, Nordic Countries, Russia, and Rest of Europe
- Asia-Pacific: Japan, India, China, South Korea, Australia & New Zealand, Indonesia, Taiwan, Singapore, and Rest of Asia-Pacific
- Asia-Pacific is set to be the fastest-growing market in the global joint pain injections market.
- Osteoarthritis is highly common among the elder population. The Population Reference Bureau projected that by 2050, 366 million people in China would be aged 65 or more.
- Also, the market is driven by the substantial population base in countries such as China and India, the increasing focus of market players in the region, and the introduction of new products or therapies.
- Rest of World: Latin America, the Middle East & Africa
Major market players in the global joint pain injections market:
- Anika Therapeutics Inc
- Sanofi
- Zimmer Biomet
- Bioventus
- Ferring Pharmaceuticals Inc
Key strategies adopted by some of these companies:
In March 2021, the Collaboration of Seikagaku Corporation and Ono Pharmaceutical Co Ltd announced manufacturing and marketing approval for its JOYCLU, an intra-articular injection for the hip joint and knee pain in Japan’s market.
Key findings of the global joint pain injections market:
- The global joint pain injections market harbors lucrative opportunities for pharmaceutical manufacturing companies, especially in developing sectors.
- Product innovations play an integral role in fueling the global joint pain injections market.
Frequently Asked Questions (FAQs):
- How does the prevalence of the aging population drive the global joint pain injections market?
A: The surging aging population results in several joint-related diseases such as rheumatoid arthritis, osteoarthritis, tendinitis, as well as an increased risk of arthritis. Therefore, the rising aging population propels the global joint pain injections market.
- Which segment captures the highest market share in the injection type category?
A: Hyaluronic acid is the largest revenue-generating injection type as it is a naturally occurring body fluid. Besides, it plays a major role in the lubrication and cushioning of joints.
- Which is the fastest-growing distribution channel in the global joint pain injections market?
A: Hospitals pharmacies is the fastest-growing distribution channel in the global joint pain injections market.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- PARENT MARKET ANALYSIS: ORTHOPEDIC PROCEDURES MARKET
- KEY DRIVERS
- BONE AND JOINT-RELATED DISEASES IN THE GERIATRIC POPULATION
- GROWING NUMBER OF SPORT INJURIES
- PREVALENCE OF MUSCULOSKELETAL DISORDERS
- KEY RESTRAINTS
- HIGH COSTS OF JOINT REPAIR THERAPIES
- SIDE EFFECTS ASSOCIATED WITH JOINT REPAIR INJECTIONS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON JOINT PAIN INJECTIONS MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- NEW ENTRY
- SUBSTITUTION
- INDUSTRY RIVALRY
- KEY BUYING CRITERIA
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY JOINT TYPE
- KNEE
- SHOULDER AND ELBOW
- HIP
- FOOT AND ANKLE
- OTHER JOINT TYPES
- MARKET BY INJECTION TYPE
- HYALURONIC ACID
- CORTICOSTEROID
- OTHER DRUGS
- MARKET BY DISTRIBUTION CHANNEL
- HOSPITALS PHARMACIES
- RETAIL PHARMACIES
- OTHER DISTRIBUTION CHANNELS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- GERMANY
- FRANCE
- UNITED KINGDOM
- ITALY
- SPAIN
- NORDIC COUNTRIES
- RUSSIA
- REST OF EUROPE
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- AUSTRALIA & NEW ZEALAND
- SOUTH KOREA
- INDONESIA
- TAIWAN
- SINGAPORE
- REST OF ASIA-PACIFIC
- REST OF WORLD
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- REGIONAL ANALYSIS
- LATIN AMERICA
- MIDDLE EAST & AFRICA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
- COMPANY PROFILES
- ALLERGAN PLC (ACQUIRED BY ABBVIE)
- ANIKA THERAPEUTICS INC
- BIOVENTUS INC
- CHUGAI PHARMACEUTICAL
- FERRING PHARMACEUTICALS
- FIDIA PHARMA USA INC
- FLEXION THERAPEUTICS INC
- ORTHOGENRX INC
- PFIZER INC
- SANOFI
- SEIKAGAKU CORPORATION
- SMITH & NEPHEW PLC
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- ZIMMER BIOMET HOLDINGS
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – JOINT PAIN INJECTIONS
TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER, BY GEOGRAPHIC REGION, 2019 AND 2050
TABLE 3: GLOBAL JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 4: GLOBAL JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 5: GLOBAL KNEE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 6: GLOBAL KNEE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 7: GLOBAL SHOULDER AND ELBOW MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 8: GLOBAL SHOULDER AND ELBOW MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 9: GLOBAL HIP MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 10: GLOBAL HIP MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 11: GLOBAL FOOT AND ANKLE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 12: GLOBAL FOOT AND ANKLE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 13: GLOBAL OTHER JOINT TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 14: GLOBAL OTHER JOINT TYPES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 15: GLOBAL JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 16: GLOBAL JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 17: GLOBAL HYALURONIC ACID MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 18: GLOBAL HYALURONIC ACID MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 19: GLOBAL CORTICOSTEROID MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 20: GLOBAL CORTICOSTEROID MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 21: GLOBAL OTHER DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 22: GLOBAL OTHER DRUGS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 23: GLOBAL JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 24: GLOBAL JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 25: GLOBAL HOSPITALS PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 26: GLOBAL HOSPITALS PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 27: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 28: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 29: GLOBAL OTHER DISTRIBUTION CHANNELS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 30: GLOBAL OTHER DISTRIBUTION CHANNELS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 31: GLOBAL JOINT PAIN INJECTIONS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 32: GLOBAL JOINT PAIN INJECTIONS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 33: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 34: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 35: LEADING PLAYERS OPERATING IN THE NORTH AMERICA JOINT PAIN INJECTIONS MARKET
TABLE 36: EUROPE JOINT PAIN INJECTIONS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 37: EUROPE JOINT PAIN INJECTIONS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 38: LEADING PLAYERS OPERATING IN EUROPE JOINT PAIN INJECTIONS MARKET
TABLE 39: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 40: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 41: LEADING PLAYERS OPERATING IN ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET
TABLE 42: REST OF WORLD JOINT PAIN INJECTIONS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 43: REST OF WORLD JOINT PAIN INJECTIONS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 44: LEADING PLAYERS OPERATING IN REST OF WORLD JOINT PAIN INJECTIONS MARKET
TABLE 45: LIST OF MERGERS & ACQUISITIONS
TABLE 46: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 47: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 48: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL JOINT PAIN INJECTIONS MARKET, BY JOINT TYPE, IN 2021
FIGURE 6: GLOBAL JOINT PAIN INJECTIONS MARKET, BY KNEE, 2022-2030 (IN $ MILLION)
FIGURE 7: GLOBAL JOINT PAIN INJECTIONS MARKET, BY SHOULDER AND ELBOW, 2022-2030 (IN $ MILLION)
FIGURE 8: GLOBAL JOINT PAIN INJECTIONS MARKET, BY HIP, 2022-2030 (IN $ MILLION)
FIGURE 9: GLOBAL JOINT PAIN INJECTIONS MARKET, BY FOOT AND ANKLE, 2022-2030 (IN $ MILLION)
FIGURE 10: GLOBAL JOINT PAIN INJECTIONS MARKET, BY OTHER JOINT TYPES, 2022-2030 (IN $ MILLION)
FIGURE 11: GLOBAL JOINT PAIN INJECTIONS MARKET, BY INJECTION TYPE, IN 2021
FIGURE 12: GLOBAL JOINT PAIN INJECTIONS MARKET, BY HYALURONIC ACID, 2022-2030 (IN $ MILLION)
FIGURE 13: GLOBAL JOINT PAIN INJECTIONS MARKET, BY CORTICOSTEROID, 2022-2030 (IN $ MILLION)
FIGURE 14: GLOBAL JOINT PAIN INJECTIONS MARKET, BY OTHER DRUGS, 2022-2030 (IN $ MILLION)
FIGURE 15: GLOBAL JOINT PAIN INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, IN 2021
FIGURE 16: GLOBAL JOINT PAIN INJECTIONS MARKET, BY HOSPITALS PHARMACIES, 2022-2030 (IN $ MILLION)
FIGURE 17: GLOBAL JOINT PAIN INJECTIONS MARKET, BY RETAIL PHARMACIES, 2022-2030 (IN $ MILLION)
FIGURE 18: GLOBAL JOINT PAIN INJECTIONS MARKET, BY OTHER DISTRIBUTION CHANNELS, 2022-2030 (IN $ MILLION)
FIGURE 19: NORTH AMERICA JOINT PAIN INJECTIONS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 20: UNITED STATES JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 21: CANADA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 22: EUROPE JOINT PAIN INJECTIONS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 23: GERMANY JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 24: FRANCE JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 25: UNITED KINGDOM JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 26: ITALY JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 27: SPAIN JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 28: NORDIC COUNTRIES JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: RUSSIA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: REST OF EUROPE JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 32: CHINA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: JAPAN JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: INDIA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: AUSTRALIA & NEW ZEALAND JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: SOUTH KOREA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 37: INDONESIA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 38: TAIWAN JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 39: SINGAPORE JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 40: REST OF ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 41: REST OF WORLD JOINT PAIN INJECTIONS MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)
FIGURE 42: LATIN AMERICA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
FIGURE 43: MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET, 2022-2030 (IN $ MILLION)
- MARKET BY JOINT TYPE
- KNEE
- SHOULDER AND ELBOW
- HIP
- FOOT AND ANKLE
- OTHER JOINT TYPES
- MARKET BY INJECTION TYPE
- HYALURONIC ACID
- CORTICOSTEROID
- OTHER DRUGS
- MARKET BY DISTRIBUTION CHANNEL
- HOSPITALS PHARMACIES
- RETAIL PHARMACIES
- OTHER DISTRIBUTION CHANNELS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- EUROPE
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- GERMANY
- FRANCE
- UNITED KINGDOM
- ITALY
- SPAIN
- NORDIC COUNTRIES
- RUSSIA
- REST OF EUROPE
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- CHINA
- JAPAN
- INDIA
- AUSTRALIA & NEW ZEALAND
- SOUTH KOREA
- INDONESIA
- TAIWAN
- SINGAPORE
- REST OF ASIA-PACIFIC
- REST OF WORLD
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- REGIONAL ANALYSIS
- LATIN AMERICA
- MIDDLE EAST & AFRICA
- NORTH AMERICA
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.